Search
SOLACI Congress
Day 2

Thromboprophylaxis with antiplatelet agents in patients with mechanical aortic valves

solaci
solaci
348
0

29_raul_garcia
Raúl García-Rinaldo
2014-08-08

MD, PhD, FACS 
Ponce School of Medicine, Ponce, PR
Mayaguez Medical Center, Mayaguez, PR

Previous article
Evaluation and Management of Asymptomatic Aortic Stenosis
Next article
Hay Lugar Aun Para los Inhibidores GPIIbIIIa?
solaci
solaci

More articles by this author

Hay Lugar Aun Para los Inhibidores GPIIbIIIa?

solaci - 0
Pedro Ureña Velásquez2014-08-08FACC FSCAI FACCPDirector Medicina Cardiovascular Asociada   

Evaluation and Management of Asymptomatic Aortic Stenosis

solaci - 0
Augusto Pichard2014-08-08Director Innovation and Structural Heart Disease,  Vice Chair, Medstar Heart Institute, Medstar Washington Hospital Center. Professor of Medicine (Cardiology),Georgetown University Medical School.Washington, DC

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

solaci - 0
Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School

Percutaneous Treatment of Mitral Regurgitation

solaci - 0
Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Day 2

Hay Lugar Aun Para los Inhibidores GPIIbIIIa?

Pedro Ureña Velásquez2014-08-08FACC FSCAI FACCPDirector Medicina Cardiovascular Asociada   
solaci -
SOLACI Sessionsspot_img

Recent Articles

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Dr. Andrés Rodríguez - 0
Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Dr. Juan Manuel Pérez - 0
Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Dr. Andrés Rodríguez - 0
Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Institutional News

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

solaci - 0
The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

solaci - 0
Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy